These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16281751)

  • 1. [Delayed improvement of anemia treated with intravenous iron and epoetin alfa after hip replacement surgery].
    Bisbe E; Sáez M; Pérez C; Castillo J; García-Erce JA
    Rev Esp Anestesiol Reanim; 2005 Oct; 52(8):507-9. PubMed ID: 16281751
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin B12 and folic acid in preschool anemia.
    Singla PN; Bhardwaj B; Agarwal DK; Agarwal KN
    Indian Pediatr; 1985 Jan; 22(1):27-33. PubMed ID: 4077257
    [No Abstract]   [Full Text] [Related]  

  • 3. Correction of epoetin-resistant megaloblastic anaemia following vitamin B(12) and folate administration.
    Breen CP; Macdougall IC
    Nephron; 1999; 83(4):374-5. PubMed ID: 10575307
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing severe anemia when the patient is a Jehovah's Witness.
    Lynn S; McDaniel J
    JAAPA; 2013 Apr; 26(4):24, 27-9. PubMed ID: 23610833
    [No Abstract]   [Full Text] [Related]  

  • 5. Ferric carboxymaltose increases epoetin-α response and prevents iron deficiency before elective orthopaedic surgery.
    Rineau E; Chaudet A; Carlier L; Bizot P; Lasocki S
    Br J Anaesth; 2014 Aug; 113(2):296-8. PubMed ID: 25038162
    [No Abstract]   [Full Text] [Related]  

  • 6. Case management of the anemic patient: epoetin alfa--focus on iron supplementation.
    Kirlin LF
    ANNA J; 1993 Dec; 20(6):678-81. PubMed ID: 8267412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoetin alfa: patient management issues and development through recombinant DNA technology. Part 1: Focus on Epoetin alfa patient management and recombinant DNA technology.
    Latham D; Nichols E
    ANNA J; 1990 Aug; 17(4):311-4. PubMed ID: 2396857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Individual differences in the efficacy of Recormon in patients with terminal kidney failure. The role of iron deficiency].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kondakhchan MA; Rogov VA; Trofimova EI
    Ter Arkh; 1993; 65(6):45-8. PubMed ID: 8378849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epoetin alfa in the treatment of secondary anemia induced by chemotherapy].
    Mansueto G; Flavia L
    Tumori; 2005; 91(4):suppl 8-16. PubMed ID: 16277112
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrent aphthae: treatment with vitamin B12, folic acid, and iron.
    Wray D; Ferguson MM; Mason DK; Hutcheon AW; Dagg JH
    Br Med J; 1975 May; 2(5969):490-3. PubMed ID: 1148667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nutritional anemia].
    Horák J; Príhodová A
    Vnitr Lek; 1974 Mar; 20(3):276-86. PubMed ID: 4603715
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anemia in small intestine diseases].
    Strohmeyer G; Schmidt M
    Internist (Berl); 1966 May; 7(5):232-6. PubMed ID: 4863638
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study.
    García-Erce JA; Cuenca J; Haman-Alcober S; Martínez AA; Herrera A; Muñoz M
    Vox Sang; 2009 Oct; 97(3):260-7. PubMed ID: 19497085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and abuse of hematinics.
    Byran JA
    Am Fam Physician; 1973 Jun; 7(6):121-8. PubMed ID: 4708269
    [No Abstract]   [Full Text] [Related]  

  • 15. Postoperative high-dose intravenous iron sucrose with low dose erythropoietin therapy after total hip replacement.
    Yoon J; Kim S; Lee SC; Lim H
    Korean J Intern Med; 2010 Dec; 25(4):454-7. PubMed ID: 21179286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients.
    Schiesser D; Binet I; Tsinalis D; Dickenmann M; Keusch G; Schmidli M; Ambühl PM; Lüthi L; Wüthrich RP
    Nephrol Dial Transplant; 2006 Oct; 21(10):2841-5. PubMed ID: 16891647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.
    Henry DH; Dahl NV; Auerbach M; Tchekmedyian S; Laufman LR
    Oncologist; 2007 Feb; 12(2):231-42. PubMed ID: 17296819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ileal malabsorption of vitamin B12 in the chronic alcoholics].
    Kaltenbach G; Andres E; Imler M
    Gastroenterol Clin Biol; 1995 May; 19(5):544-5. PubMed ID: 7590011
    [No Abstract]   [Full Text] [Related]  

  • 19. Case management of the anemic patient. Epoetin alfa: focus on kinetic dosing.
    Keen ML
    ANNA J; 1990 Aug; 17(4):318-9. PubMed ID: 2396859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symposium. Crohn's disease: medical management.
    Cooke WT
    Dis Colon Rectum; 1975 Apr; 18(3):194-7. PubMed ID: 1140046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.